INGN Q1 2023 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$72M-10.2% YoY

Gross Profit

$31M42.6% margin

Operating Income

-$22M-30.4% margin

Net Income

-$20M-28.2% margin

EPS (Diluted)

$-0.88

QoQ Revenue Growth

-18.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$386M

Total Liabilities

$104M

Stockholders' Equity

$281M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$80M	-10.2%
Gross Profit	$31M	$35M	-12.2%
Operating Income	-$22M	-$14M	-61.3%
Net Income	-$20M	-$14M	-43.2%

Geographic Segments

UNITED STATES

$53M74%

Non-US

$19M26%